BioCentury | Dec 2, 2016
Company News

OpGen, Merck deal

...OpGen will perform genomic analysis, drug resistance testing and input the results into its Acuitas Lighthouse...
...OpGen will have rights to genomic IP, and the pharma will have access to OpGen's Lighthouse...
BioCentury | Mar 19, 2012
Financial News

Kala Pharmaceuticals financial update

...additional $6.2 million in seed financing, bringing the total raised to $11.2 million. New investor Lighthouse Capital Partners...
BioCentury | Mar 15, 2012
Financial News

Kala raises $6.2 million

...additional $6.2 million in seed financing, bringing the total raised to $11.2 million. New investor Lighthouse Capital Partners...
BioCentury | Oct 17, 2011
Financial News

Azelon completes venture financing

...Business: Musculoskeletal Date completed: 10/10/11 Type: Venture financing Raised: $4.5 million Investors: Prospect Venture Partners; Lighthouse Capital Partners...
BioCentury | Nov 8, 2010
Finance

Nailing down an IPO

...data with another $9 million to pay principal and interest under a loan agreement with Lighthouse Capital Partners...
BioCentury | Sep 20, 2010
Finance

Phase III Funding Bid

...fund the Phase III trials of both compounds. Some of the funds would go to Lighthouse Capital Partners...
BioCentury | Aug 23, 2010
Financial News

ARYx completes private placement of notes and warrants

...expected to close on Sept. 30. ARYx also converted $2.3 million of a loan with Lighthouse Capital Partners...
BioCentury | Jan 13, 2009
Financial News

BiPar raises $20 million

...Canaan Partners; Vulcan Capital; PolyTechnos Venture-Partners; Asset Management Co.; Quantum Technology Partners; and venture-debt lender Lighthouse Capital Partners...
BioCentury | Jun 2, 2003
Finance

Ebb & Flow

...with dexamethasone (see B8). CELG was up $0.39 to $31.49 on the week. Venture watch Lighthouse Capital Partners...
...high tech, biotech and medical device companies that have received equity investments from "top-tier" VCs. Lighthouse...
BioCentury | May 27, 2003
Financial News

Lighthouse Capital closes $366M fund

Lighthouse Capital Partners (Menlo Park, Calif.) closed its fifth fund, LCP V, at $366 million. The fund will provide secured loans to high tech, biotech and medical device companies that have received equity investments from...
Items per page:
1 - 10 of 12
BioCentury | Dec 2, 2016
Company News

OpGen, Merck deal

...OpGen will perform genomic analysis, drug resistance testing and input the results into its Acuitas Lighthouse...
...OpGen will have rights to genomic IP, and the pharma will have access to OpGen's Lighthouse...
BioCentury | Mar 19, 2012
Financial News

Kala Pharmaceuticals financial update

...additional $6.2 million in seed financing, bringing the total raised to $11.2 million. New investor Lighthouse Capital Partners...
BioCentury | Mar 15, 2012
Financial News

Kala raises $6.2 million

...additional $6.2 million in seed financing, bringing the total raised to $11.2 million. New investor Lighthouse Capital Partners...
BioCentury | Oct 17, 2011
Financial News

Azelon completes venture financing

...Business: Musculoskeletal Date completed: 10/10/11 Type: Venture financing Raised: $4.5 million Investors: Prospect Venture Partners; Lighthouse Capital Partners...
BioCentury | Nov 8, 2010
Finance

Nailing down an IPO

...data with another $9 million to pay principal and interest under a loan agreement with Lighthouse Capital Partners...
BioCentury | Sep 20, 2010
Finance

Phase III Funding Bid

...fund the Phase III trials of both compounds. Some of the funds would go to Lighthouse Capital Partners...
BioCentury | Aug 23, 2010
Financial News

ARYx completes private placement of notes and warrants

...expected to close on Sept. 30. ARYx also converted $2.3 million of a loan with Lighthouse Capital Partners...
BioCentury | Jan 13, 2009
Financial News

BiPar raises $20 million

...Canaan Partners; Vulcan Capital; PolyTechnos Venture-Partners; Asset Management Co.; Quantum Technology Partners; and venture-debt lender Lighthouse Capital Partners...
BioCentury | Jun 2, 2003
Finance

Ebb & Flow

...with dexamethasone (see B8). CELG was up $0.39 to $31.49 on the week. Venture watch Lighthouse Capital Partners...
...high tech, biotech and medical device companies that have received equity investments from "top-tier" VCs. Lighthouse...
BioCentury | May 27, 2003
Financial News

Lighthouse Capital closes $366M fund

Lighthouse Capital Partners (Menlo Park, Calif.) closed its fifth fund, LCP V, at $366 million. The fund will provide secured loans to high tech, biotech and medical device companies that have received equity investments from...
Items per page:
1 - 10 of 12